openPR Logo
Press release

Glaucoma Therapeutics Market Demand, Size, Share, Scope & Forecast to 2030

09-21-2022 11:17 AM CET | Health & Medicine

Press release from: We Market Research

Glaucoma Therapeutics Market

Glaucoma Therapeutics Market

The Global Glaucoma Therapeutics market is expected to grow to a value of more than USD 11.05 billion by 2030, with a growing CAGR (compound annual growth rate) of 6.1% from 2022 to 2030.

Glaucoma Therapeutics- Overview
Glaucoma is a condition that damages the optic nerve and, if left untreated, can lead to blindness and vision loss. Topical eye drops from the prostaglandins, beta blockers, alpha agonist, combination drug, carbonic anhydrase inhibitor, and cholinergic classes are the first line of glaucoma treatment. The administration of these eye drops lowers intraocular pressure by reducing the formation of the fluid inside the eyes. Topical eye drops might be used as an alternative to surgery or to postpone surgery.

Key market trends- Growth determinants and restraints
The Global Glaucoma Therapeutics Market is developing at a quicker pace with significant development rates throughout the most recent couple of years and is assessed that the market will fill essentially in the gauge period for example 2022 to 2030.

One of the main factors fuelling the market's expansion is the rising incidence of glaucoma in the world. Patients with diabetes and other eye conditions, such as age-related macular degeneration (AMD), cataract, and dry eye, are far more likely to develop glaucoma.

In keeping with this, the growing elderly population, which is more prone to certain illnesses, is encouraging market expansion. Additionally, increased interest in laser glaucoma surgery and rising health consciousness among the populace are contributing to the market's expansion.

Moreover, the creation of creative combo dugs is another driver pushing growth. To manage the increased levels of IOP, pharmaceutical companies are developing anti-glaucoma medications and prostaglandin analogues coupled with two or more medications.

Get Free Sample Report: https://wemarketresearch.com/sample-request/glaucoma-therapeutics-market/400/

Segmentation Analysis of Global Glaucoma Therapeutics market
Based on drug class
• Beta blockers
• Prostaglandins analogs- latanoprost, bimatoprost, travoprost.

• Alpha adrenergic agonists
• Carbonic anhydrase inhibitors
• Combination drugs
• Others

Based on disease indication
• Open angle glaucoma
• Angle closure glaucoma
• Others

Based on distribution channel
• Hospital pharmacy
• Retail pharmacy
• Online pharmacy
• others

Asia-Pacific is expected to hold the largest market share

North America, Europe, Latin America, Asia Pacific, and Middle East and Africa are the major regions constituting the geographical landscape of Global Glaucoma Therapeutics market. Asia-Pacific dominates the market with the largest market share among others.

Competitive Landscape
The Key players in the Global Glaucoma Therapeutics Market are Allergan, Inc., Merck & Co., Pfizer, Inc., Novartis AG., Santen Pharmaceuticals, Valeant Pharmaceuticals, and Aerie Pharmaceuticals, and others.

Major development
• The Global Glaucoma Therapeutics market is expected to increase at a significant rate during the figure time period, somewhere in the range of 2022 to 2030. In 2020, the market was developing at a consistent rate and with the increasing reception of systems by key players, the market is supposed to ascend over the projected skyline.

For More Details, Visit Our Report Page:https://wemarketresearch.com/reports/glaucoma-therapeutics-market/400/

Frequently Asked Questions
1 ) What is the growth rate of the Global Glaucoma Therapeutics Market?
2) What are the primary growth determinants of the Global Glaucoma Therapeutics market?
3) Which are the major regions constituting this Market?
4) Which are the prominent companies operating in this Market?

Contact Us:
We Market Research
Phone: +1(650)-666-4592
Email: sales@wemarketresearch.com
Web: https://wemarketresearch.com/

About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glaucoma Therapeutics Market Demand, Size, Share, Scope & Forecast to 2030 here

News-ID: 2743326 • Views:

More Releases from We Market Research

Semiconductor Manufacturing Equipment Market Is Projected To Reach USD 149,700 Million By 2033, Growing At A CAGR Of 10.5% During The Forecast Period
Semiconductor Manufacturing Equipment Market Is Projected To Reach USD 149,700 M …
The global Semiconductor Manufacturing Equipment market size was valued at USD 91,200 million in 2022 and is projected to reach USD 149,700 million by 2033, growing at a CAGR of 10.5% during the forecast period. Equipment used to generate different semiconductor goods is referred to as semiconductor equipment and is a crucial supporting component in the semiconductor industrial chain. The semiconductor business is technologically led by semiconductor equipment. The creation of
Satellite Ground Station Market Is Projected To Reach USD 115,860 Million By 2033, Growing At A CAGR Of 13.8% During The Forecast Period
Satellite Ground Station Market Is Projected To Reach USD 115,860 Million By 203 …
The global Satellite Ground Station market size was valued at USD 61,350 million in 2022 and is projected to reach USD 115,860 million by 2033, growing at a CAGR of 13.8% during the forecast period. The market for buildings, furnishings, and devices that are used to communicate with and manage satellites is referred to as the global satellite ground station market. Establishing communication channels, sending and receiving data, and managing satellite
Video Surveillance as a Service (VSaaS) Market Analysis by Type, Vertical -Forecast to 2032
Video Surveillance as a Service (VSaaS) Market Analysis by Type, Vertical -Forec …
Introduction The global video surveillance as a service (VSaaS) market has witnessed substantial growth in recent years. With advancements in technology and the increasing need for enhanced security measures, businesses and organizations are turning to VSaaS solutions to monitor and protect their assets. This article explores the key aspects of the Global Video Surveillance As A Service Market, including market trends, growth drivers, and the major players in the industry. Click Here,
R600a Refrigerant Market by Type, By Application And By Region, Forecast From 2023 To 2032
R600a Refrigerant Market by Type, By Application And By Region, Forecast From 20 …
Introduction Welcome to our in-depth analysis of the Global R600a Refrigerant Market. In this article, we will explore the various aspects of the market, including its current state, growth prospects, key players, and future trends. R600a refrigerant, also known as isobutane, is a hydrocarbon with excellent thermodynamic properties that make it suitable for a wide range of refrigeration applications. With increasing concerns about environmental impact, R600a has gained significant traction due

All 5 Releases


More Releases for Glaucoma

Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the
Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1159 The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the
Market Spotlight: Glaucoma
Boston, MA ReportsWorldwide has announced the addition of a new report title Market Spotlight: Glaucoma to its growing collection of premium market research reports. Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid
North America Glaucoma Therapeutics Market grows with growing awareness regardin …
Glaucoma Therapeutics Market: Scope and Methodology The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study
Glaucoma Treatment Market : Rising Geriatric Population And Healthcare Expenditu …
Glaucoma is a chronic, degenerative, permanent disorder whose rate increases essentially with age rather than causing immediate blindness. According to a survey of WHO, Glaucoma is the second most common cause of blindness affecting the population worldwide after cataract (47.9%). In general, Glaucoma occurs as after effects of increased intraocular pressure (IOP) brought about by an abnormality or malfunctioning of the eye drainage system. The normal IOP is in
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and